Evaluation of the Ovarian Reserve in Infertile Patients With Endometriosis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01941017

Enrollment

Registered

2013-09-13

Start date

2009-04-30

Completion date

2012-03-31

Last updated

2013-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Brief summary

Comparison between Ovarian reserve markers in patients with minimal/mild endometriosis and patients with tubal factor infertility

Detailed description

Comparison between Ovarian reserve markers (laboratory or us) in patients with minimal/mild endometriosis and patients with tubal factor infertility including: Cycle Day 2 or 3 FSH and E2, Serum AMH and antral follicular count

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 35 Years

Healthy volunteers

Inclusion criteria

Age 18-35 years of age. Written and signed informed consent by the patient to participate in the study. Patients with regular menses, both ovaries, serum TSH within normal range, body mass index (BMI) \<30 kg/m2 with normal sperm analysis of the husband.

Exclusion criteria

Patients with previous endocrine disorders. Cases in which the cause for infertility was other than endometriosis (except for patients with tubal obstruction, in the control group). Patient with previous surgery for endometriosis.

Design outcomes

Primary

Measure	Time frame	Description
Assessment of ovarian reserve in the 2 groups	2 years	Serum AMH and antral follicular count (AFC)

Secondary

Measure	Time frame	Description
Other Hormonal parameters	2 years	Cycle day 2 or 3 FSH and E2

Outcome results